BioCryst Pharmaceuticals Inc (BCRX) Stock Price, Quote, News & History

BCRXNASDAQ
$8.62
-0.28-3.15%
At close: May 8, 5:00 PM EST
$8.60
-0.0181-0.21%
After Hours: May 8, 7:27 PM EST
Earnings: Q1 2026 Earnings were released on Wed May 6th, before the market open
Conference Call: The most recent conference call started at 8:30 AM, 5 days ago
Click to view the webcast

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
313.10M
Investing Cash Flow (TTM)
-309.44M
Financing Cash Flow (TTM)
62.09M
Free Cash Flow (TTM)
310.37M
Capital Expenditure (TTM)
-2.73M
Net Change in Cash (TTM)
65.75M

Analyst Trends and Forecast

1
Dec 25
1
Jan
2
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.77B
PE Ratio (TTM)
-
PE Ratio (FWD)
111.11
PEG Ratio (TTM)
-
PS Ratio (TTM)
2.26
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-19.89%
Earnings Yield % (FWD)
0.90%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
6.46
Book Value / Share
-$2.18

Company Debt

Total Debt
$802.38M
LT Debt
$802.38M
LT Debt Issuance (TTM)
$400.00M
LT Debt Repayment (TTM)
-$301.82M
Total Cash
$171.59M
Debt to Equity
-
Issuance of Debt (TTM)
$98.18M
Repayment of Debt (TTM)
-$301.82M

Key Statistics

Open
$8.96
Close
$8.62
Volume / Avg.
6.16M / 5.21M
Day Range
$8.56 - $8.99
52 Wk Range
6.00 - 11.31
Market Cap
$2.19B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
15.28%
Days to Cover
8.02

About

Sector
Health Care
Industry
Biotechnology
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple sci...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BioCryst Pharma (BCRX) stock?

A

You can purchase shares of BioCryst Pharma (NASDAQ:BCRX) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for BioCryst Pharma (BCRX) stock?

A

BioCryst Pharma has a consensus price target of $20.07.

Q

What is the current price for BioCryst Pharma (BCRX)?

A

The stock price for BioCryst Pharma (NASDAQ: BCRX) is $8.6019 last updated May 8, 2026 at 7:27 PM EDT.

Q

Does BioCryst Pharma (BCRX) pay a dividend?

A

There are no upcoming dividends for BioCryst Pharma.

Q

When is BioCryst Pharma (NASDAQ:BCRX) reporting earnings?

A

BioCryst Pharma does not have any upcoming earnings scheduled.

Q

Is BioCryst Pharma (BCRX) going to split?

A

There is no upcoming split for BioCryst Pharma.

Q

What sector and industry does BioCryst Pharma (BCRX) operate in?

A

BioCryst Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.